Neoadjuvant systemic and intravesical chemotherapy with partial cystectomy for muscle invasive bladder cancer with concomitant CIS

The presence of carcinoma in situ (CIS) is traditionally a contraindication to bladder-sparing approaches for muscle invasive bladder cancer (MIBC). Strategies that might aid in bladder preservation for this population require further investigation. We report a case of MIBC with CIS treated with bot...

Descripción completa

Detalles Bibliográficos
Autores principales: Plambeck, Benjamin D., Tazegul, Tutku E., McElree, Ian M., Steinberg, Ryan L., Packiam, Vignesh T., O'Donnell, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461041/
https://www.ncbi.nlm.nih.gov/pubmed/37645679
http://dx.doi.org/10.1016/j.eucr.2023.102516
Descripción
Sumario:The presence of carcinoma in situ (CIS) is traditionally a contraindication to bladder-sparing approaches for muscle invasive bladder cancer (MIBC). Strategies that might aid in bladder preservation for this population require further investigation. We report a case of MIBC with CIS treated with both neoadjuvant systemic and intravesical chemotherapy prior to partial cystectomy.

Ejemplares similares